Pharmaceutical

Bayer reports drop in Q1 sales amidst patent litigation challenges

Bayer announced a fall in Q1 sales and predicted future challenges in the Xarelto market in its Q1 update.

May 15, 2024 - 04:00
Bayer reports drop in Q1 sales amidst patent litigation challenges
Bayer announced a fall in Q1 sales and predicted future challenges in the Xarelto market in its Q1 update.
Read the original article

Tags:

Previous Article

UTA biology students receive awards for excellence

Next Article

Walden Biosciences teams up with Primula for kidney disease study 

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: David Liu startup to focus on getting CRISPR therapy to hard-to-reach cells

STAT+: David Liu startup to focus on getting CRISPR the...

Sep 18, 2023

STAT+: Biden defends Trump-era drug pricing rule on copay accumulators

STAT+: Biden defends Trump-era drug pricing rule on cop...

Nov 29, 2023

Embracing digital solutions for enhanced patient care

Embracing digital solutions for enhanced patient care

Jun 30, 2024